Deadline is approaching! Are you doing research in #EGFR+ #lungcancer — OR mentoring someone who is — submit an abstract to the EGFR Resisters Research Summit Concepts welcome Deadline-August 8. Submit Abstract - ceconcepts.com/egfr-summit #NSCLC #ThoracicOnc #HOFellows #EGFRResisters #OncoAlert

Heading to #ASCO25 this year? Be sure to join us for the first ever #ASPIRE Community of Practice on Friday, May 30th: 4-6pm CST in E253cd. We have a great agenda and opportunity to connect with other #irAE aficionados @ascocancer.bsky.social @funchainmd.bsky.social www.asco.org/annual-meeti...

Sick and tired of being sick and tired? Thanks @funchainmd.bsky.social & Afreen Shariff for the chance to discuss cancer-related fatigue @ascocancer.bsky.social @americancancersoc.bsky.social @pallonccop.bsky.social @oncoalert.bsky.social @aspire-cop.bsky.social podcasts.apple.com/us/podcast/e...

Welcome #pallonc #supponc folks to the official Blue Sky account for ASCO supported #PallOncCoP. Please follow for official Zoom meeting events, in-person conference meet ups like pic #ASCO24 and sharing the latest science in comfort and cure.

I will co-chair with Prof Maryam Lustberg on June 26th AM "Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment." bringing together multidisciplinary professionals, cancer patients, survivors and carers to compare best practices for management toxicities.

My Guiding Compass in Advocacy: Speak up, but do it with respect. Challenge, but do it with understanding. And always push forward with purpose — Real change happens through conversation, not confrontation. I was 28 when my mom died, but her profound wisdom always guides me 💙

Jill Feldman wrote a powerful article for @curetoday.bsky.social about the #LungCancerGeneticsStudy – a collaboration between nearly two dozen #LungCancer organizations and 23andme to uncover the genetic risks of lung cancer. Read it at: www.curetoday.com/view/the-pow... @jillfeldman4.bsky.social

ASCO has a palliative care community of practice in which a patient advocate pillar was organized with @jillfeldman4.bsky.social, Ameish, and I as members. I have served since September 2023 as the lead and will hand over the role later this year.

Please email [email protected] to be added to the listserv.

Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si #LCSM #EndStigmaNow

THIS! Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer. Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏 #LCSM #SuppOnc bit.ly/4jiKwUz

What a pleasure it was to meet Donghoon Shin! His passion and desire to learn from patient advocates was genuine and impressive. The future of #lungcancer research is bright😎 #LCSM #EGFR

ICYMI "We must rethink how we define progress in oncology" #Oncosky #Cansky #Pallonc

“The most common cause of death from cancer is from lung cancer…yet just 16% of eligible people get screened for lung cancer, far lower than screening rates for colorectal or breast cancer. “ #medsky ktul.com/news/nation-...

Innovation shouldn't come at the expense of patient-centered care! Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary. We must rethink how we define progress in #oncology #pallonc #LCSM bit.ly/3OJQuQB

Only this week a patient asked me if thought she was foolish for declining further treatment. She is not foolish, it is the right decision for her.

It was an honor to co-author this article bit.ly/40WN9Vr It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face. It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care. #LCAM #LCSM

Working on the #ASCO #SCLC guidelines, published in 2023, was disheartening, but working on the rapid update (based on #ASCO24 data) left me emotional. This update represents hope & progress for patients who have waited far too long. ascopubs.org/doi/10.1200/... #LCSM

Today's the day! Our last PallOncCoP meeting of 2024! Don't miss it. Not too late to DM📨 for Zoom 🔗. Always stay in the know by sending your prof email to [email protected] to be added to our listserv. @darcyburbage.bsky.social @tingtingzhang.bsky.social @jillfeldman4.bsky.social

The #lungcancer screening team at RushCancer Center has had a 50% uptake in screening for the 3rd year! Congratulations to Annie and the team, and thank you for your tireless efforts to raise awareness about lung cancer screening! #LCSM #LCAM #EarlyDetectionSavesLives

Great episode Dr Ross Camidge's podcast #HowThisIsBuildingMe with pharmacologist Dr. Zirkelbach (FDA Onc) on drug dev & her focus on #PROs for best outcomes w/fewest AEs I always learn, but still have questions about #ProjectOptimus bit.ly/48RlOpz #LCAM #LCSM #TheRightDose @itsnotpink.bsky.social

📢 The @ASCO released updated living guidelines for treating stage IV #NSCLC with driver alterations! ascopubs.org/doi/10.1200/.... This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance. #LCSM #LCAM

The "Living" #ASCOGuidelines embraces change and supports #OncSky clinicians and people LIVING with mutation-driven lung cancer in making informed treatment choices. Congrats to the expert panel! ascopubs.org/doi/full/10.... @jillfeldman4.bsky.social #LCSM

Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat. Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3

"the new generation of cancer survivor [is] younger, less financially secure, and still having to navigate life after treatment, from dating to career, sex and child rearing" So glad that #AYAcsm #survonc #financialToxicity & #MBC issues are getting time on NPR www.npr.org/2024/11/11/n...

I made a #LCSM list, small but growing! Not sure how to make it public? bsky.app/profile/did:... @jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social